爱尔兰社区老年人处方瀑布现象:基于国家数据库的处方序列对称性分析
该研究利用爱尔兰国家处方数据库,对2017至2020年间533464名65岁及以上社区老年人的处方进行序列对称性分析,评估9种ThinkCascades处方瀑布的流行率、强度及效应修饰。结果发现5种处方瀑布具有显著阳性调整序列比,其中钙通道阻滞剂至利尿剂瀑布信号最强(患病率2.6%,aSR=1.93,95%CI 1.79-2.09)。研究提示处方瀑布是老年人多重用药中值得关注但研究不足的领域。
要点
- 5种处方瀑布呈显著阳性信号,钙通道阻滞剂至利尿剂瀑布信号最强(aSR=1.93)。
- α1受体阻滞剂至前庭镇静剂、SSRI/SNRI至助眠药等瀑布也显示阳性信号。
- 处方瀑布在社区老年人中患病率范围为0.4%至3.2%,需在多重用药管理中警惕。
核心结论
- 在爱尔兰社区老年人中识别出5种具有临床相关性的处方瀑布,其中钙通道阻滞剂至利尿剂瀑布信号最强。
- 处方瀑布是导致老年人复杂多重用药的重要但研究不足的领域。
研究设计与样本
- 研究采用处方序列对称性分析,数据来源于爱尔兰全科医疗服务计划下初级保健配药的国家处方数据库。
- 分析基于2017至2020年间533464名65岁及以上成年人的处方数据。
- 纳入每个ThinkCascades药物对的 incident users,观察窗口为365天,并进行敏感性分析调整其他窗口。
- 调整序列比(aSR)考虑了处方的时间趋势,并按性别、年龄和个别索引药物进行分层分析。
主要发现
- 钙通道阻滞剂至利尿剂瀑布:患病率2.6%,aSR=1.93(95%CI 1.79-2.09)。
- α1受体阻滞剂至前庭镇静剂瀑布:患病率3.0%,aSR=1.63(95%CI 1.46-1.81)。
- SSRI/SNRI至助眠药瀑布:患病率2.5%,aSR=1.54(95%CI 1.40-1.69)。
- 抗精神病药至抗帕金森病药瀑布:患病率0.4%,aSR=1.20(95%CI 1.00-1.43)。
- 苯二氮䓬类药物至抗精神病药瀑布:患病率3.2%,aSR=1.15(95%CI 1.08-1.21)。
关键数值与推荐
- 阳性信号定义为调整序列比(aSR)显著大于1,表明索引药物更可能在标记药物之前被处方。
- 研究评估了9种基于专家共识的ThinkCascades处方瀑布,其中5种显示显著阳性aSR。
临床怎么用
- 全科医生在管理老年人多重用药时,应警惕处方瀑布现象,尤其是钙通道阻滞剂后加用利尿剂、α1受体阻滞剂后加用前庭镇静剂等常见组合。
- 对于使用SSRI/SNRI、抗精神病药、苯二氮䓬类药物的老年患者,应监测是否因药物不良反应而新增相关药物,及时识别并干预处方瀑布。
局限性
- 研究基于处方数据库,可能无法完全反映实际用药依从性和非处方药使用情况。
- 处方序列对称性分析为观察性设计,不能完全排除混杂因素,仅提示关联而非因果。
- 研究仅纳入爱尔兰全科医疗服务计划覆盖人群,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prescribing cascades occur when one medication is used to treat adverse effects of another medication. Older adults with polypharmacy are at higher risk for this phenomenon. We examined the prevalence, magnitude, and effect modification of 9 prescribing cascades (ThinkCascades) among older community-dwelling adults in a national prescription database. METHODS: We used prescription sequence symmetry analysis to examine prescriptions for ThinkCascades medications dispensed in primary care under the General Medical Services scheme in Ireland. Analyses were based on prescriptions dispensed between 2017 and 2020 among 533,464 adults aged 65 years or older. Incident users of both medications in each ThinkCascades dyad were included. We used an observation window of 365 days and examined other windows in sensitivity analyses. Adjusted sequence ratios (aSRs) took into account secular prescribing trends. We also conducted analyses stratified by sex, age, and individual index medication. RESULTS: Five prescribing cascades had significant positive aSRs, indicating that the patient was more likely to receive the index medication before the marker medication. The largest signal was identified for the calcium channel blocker to diuretic cascade (prevalence, 2.6%; aSR = 1.93; 95% CI, 1.79-2.09). Positive signals were also identified for the α 1-receptor blocker to vestibular sedative cascade (prevalence, 3.0%; aSR = 1.63; 95% CI, 1.46-1.81); the selective serotonin reuptake inhibitor/selective norepinephrine reuptake inhibitor to sleep medication cascade (prevalence, 2.5%; aSR = 1.54; 95% CI, 1.40-1.69); the antipsychotic to antiparkinsonian cascade (prevalence, 0.4%; aSR = 1.20; 95% CI, 1.00-1.43); and the benzodiazepine to antipsychotic cascade (prevalence, 3.2%; aSR = 1.15; 95% CI, 1.08-1.21). CONCLUSIONS: To our knowledge, this study is the first to describe the prevalence of an expert consensus-based list of prescribing cascades, ThinkCascades, in a national population of older adults, and it identified 5 clinically relevant prescribing cascades. These findings highlight prescribing cascades as an important underresearched area contributing to complex polypharmacy among older people living with multimorbidity.
引用
- Doherty AS, Lund LC, Moriarty F, et al. Prescribing Cascades Among Older Community-Dwelling Adults: Application of Prescription Sequence Symmetry Analysis to a National Database in Ireland. Ann Fam Med. 2025. PMID: 40494622. doi:10.1370/afm.240383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。